The 401-bed acute care hospital has more than 500 faculty physicians. Here are five things to know about the new trial:
1. Patrick Hsieh, MD, was named the principal investigator at the site. He is the director of the neurosurgery spine program and an associate professor of neurological surgery at the hospital.
2. This is an ongoing clinical trial and the company will soon reopen the trial for concurrent enrollment of the final three patients.
3. This is the first clinical study of the Neuro-Spinal Scaffold which has FDA approval and is designed for patients who have spinal cord injuries.
4. Keck Hospital of USC’s urban location and multidisciplinary team of experienced sub-investigators will bring benefit to the research trial.
5. When this five-patient study is complete, InVivo plans to conduct another study to obtain FDA approval to commercialize under a Humanitarian Device Exemption.
More articles on orthopedic devices:
Stryker launches its next generation viable bone matrix
Zyga Technology launches updated SImmetry Saroiliac Joint Fusion System
Exactech introduces new solutions: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.